Category - New Drugs
FDA Approves Avsola (infliximab-axxq), a Biosimilar to Remicade
FDA Approves Genentech’s Tecentriq Plus Chemotherapy (Abraxane and Carboplatin) for The Initial Treatment of Metastatic Non-Squamous Non-Small Cell Lung Cancer
FDA Approves RediTrex (methotrexate) for Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, and Psoriasis
FDA Approves Oxbryta (voxelotor) for the Treatment of Sickle Cell Disease
FDA Approves Exservan (riluzole) Oral Film for the Treatment of Amyotrophic Lateral Sclerosis
FDA Approves Xcopri (cenobamate) for the Treatment of Partial-Onset Seizures in Adults
FDA Approves Calquence for Adults with Chronic Lymphocytic Leukemia
FDA Approves Givlaari (givosiran) for Acute Hepatic Porphyria